BI Asset Management Fondsmaeglerselskab’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.4M | Sell |
180,544
-42,101
| -19% | -$4.52M | 0.19% | 115 |
|
|
2025
Q1 | $22.5M | Sell |
222,645
-47,462
| -18% | -$4.79M | 0.25% | 86 |
|
|
2024
Q4 | $24.1M | Buy |
270,107
+141,398
| +110% | +$12.6M | 0.25% | 87 |
|
|
2024
Q3 | $10.8M | Sell |
128,709
-27,125
| -17% | -$2.27M | 0.19% | 108 |
|
|
2024
Q2 | $12M | Buy |
155,834
+50,163
| +47% | +$3.86M | 0.2% | 103 |
|
|
2024
Q1 | $7.24M | Buy |
105,671
+73,219
| +226% | +$5.01M | 0.14% | 133 |
|
|
2023
Q4 | $1.88M | Sell |
32,452
-17,099
| -35% | -$988K | 0.04% | 299 |
|
|
2023
Q3 | $2.62M | Sell |
49,551
-1,076
| -2% | -$56.8K | 0.06% | 223 |
|
|
2023
Q2 | $2.74M | Buy |
50,627
+9,113
| +22% | +$493K | 0.06% | 212 |
|
|
2023
Q1 | $2.08M | Sell |
41,514
-4,701
| -10% | -$235K | 0.06% | 229 |
|
|
2022
Q4 | $2.14M | Buy |
46,215
+23,798
| +106% | +$1.1M | 0.06% | 217 |
|
|
2022
Q3 | $868K | Sell |
22,417
-2,827
| -11% | -$109K | 0.04% | 213 |
|
|
2022
Q2 | $941K | Buy |
25,244
+13,528
| +115% | +$504K | 0.04% | 237 |
|
|
2022
Q1 | $519K | Buy |
+11,716
| New | +$519K | 0.02% | 305 |
|
|
2020
Q4 | – | Sell |
-3,906
| Closed | -$149K | – | 389 |
|
|
2020
Q3 | $149K | Buy |
+3,906
| New | +$149K | 0.01% | 416 |
|